Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive value of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma.
Inubushi M, Saga T, Koizumi M, Takagi R, Hasegawa A, Koto M, Wakatuki M, Morikawa T, Yoshikawa K, Tanimoto K, Fukumura T, Yamada S, Kamada T. Inubushi M, et al. Among authors: koto m. Ann Nucl Med. 2013 Jan;27(1):1-10. doi: 10.1007/s12149-012-0652-x. Epub 2012 Aug 23. Ann Nucl Med. 2013. PMID: 22914968 Clinical Trial.
Radiographic pulmonary and pleural changes after carbon ion irradiation.
Nishimura H, Miyamoto T, Yamamoto N, Koto M, Sugimura K, Tsujii H. Nishimura H, et al. Among authors: koto m. Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):861-6. doi: 10.1016/s0360-3016(02)04495-4. Int J Radiat Oncol Biol Phys. 2003. PMID: 12605963 Clinical Trial.
Carbon ion radiotherapy for stage I non-small cell lung cancer.
Miyamoto T, Yamamoto N, Nishimura H, Koto M, Tsujii H, Mizoe JE, Kamada T, Kato H, Yamada S, Morita S, Yoshikawa K, Kandatsu S, Fujisawa T. Miyamoto T, et al. Among authors: koto m. Radiother Oncol. 2003 Feb;66(2):127-40. doi: 10.1016/s0167-8140(02)00367-5. Radiother Oncol. 2003. PMID: 12648784 Clinical Trial.
Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen.
Miyamoto T, Baba M, Yamamoto N, Koto M, Sugawara T, Yashiro T, Kadono K, Ezawa H, Tsujii H, Mizoe JE, Yoshikawa K, Kandatsu S, Fujisawa T; Working Group for Lung Cancer. Miyamoto T, et al. Among authors: koto m. Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):750-8. doi: 10.1016/j.ijrobp.2006.10.006. Int J Radiat Oncol Biol Phys. 2007. PMID: 17293232 Clinical Trial.
Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week.
Miyamoto T, Baba M, Sugane T, Nakajima M, Yashiro T, Kagei K, Hirasawa N, Sugawara T, Yamamoto N, Koto M, Ezawa H, Kadono K, Tsujii H, Mizoe JE, Yoshikawa K, Kandatsu S, Fujisawa T; Working Group for Lung Cancer. Miyamoto T, et al. Among authors: koto m. J Thorac Oncol. 2007 Oct;2(10):916-26. doi: 10.1097/JTO.0b013e3181560a68. J Thorac Oncol. 2007. PMID: 17909354 Free article. Clinical Trial.
(18)F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer.
Jingu K, Kaneta T, Nemoto K, Takeda K, Ogawa Y, Ariga H, Koto M, Sakayauchi T, Takai Y, Takahashi S, Yamada S. Jingu K, et al. Among authors: koto m. Int J Clin Oncol. 2010 Apr;15(2):184-90. doi: 10.1007/s10147-010-0044-y. Epub 2010 Mar 10. Int J Clin Oncol. 2010. PMID: 20217449
Feasibility of carbon ion radiotherapy for locally advanced sinonasal adenocarcinoma.
Koto M, Hasegawa A, Takagi R, Sasahara G, Ikawa H, Mizoe JE, Jingu K, Tsujii H, Kamada T, Okamoto Y; Organizing Committee for the Working Group for Head-and-Neck Cancer. Koto M, et al. Radiother Oncol. 2014 Oct;113(1):60-5. doi: 10.1016/j.radonc.2014.09.009. Epub 2014 Oct 3. Radiother Oncol. 2014. PMID: 25287484
167 results